Innovations in cancer treatment, such as targeted therapies and immunotherapies, have revolutionized patient care but often come at a high cost. While these treatments can improve survival rates and quality of life, they also contribute to the overall financial burden. Efforts to develop cost-effective treatments and improve access to affordable care are essential to ensure that advancements benefit as many patients as possible.
